Remember Martin Shkreli ?
He’s the jackass who bought a company that produced a generic drug –considered standard of care for treating a life-threatening parasitic infection– that sold for $13.50 per pill and immediately raised the price to $750 a pill.
Yeah – he’s a worthless motherfucker, all right.
For every yin there is a yang: meet Mark Baum, CEO of Imprimis.
Imprimis is a San Diego-based drug compounding company which announced last Thursday it would compete with Shkreli’s Turing Pharmaceuticals by offering the exact same drug for $1 a pill.